Curatis Holding AG | WebDisclosure

PRESS RELEASE

published on 05/23/2025 at 07:00, 8 months 28 days ago

Curatis discloses Corticorelin as active substance of C-PTBE-01 | Market Opportunity in PTBE expected to exceed USD 1 billion | Strengthens team with Dr. Kirsty Crame and Dr. Timm Trenktrog
Curatis Holding AG reveals Corticorelin as active substance of C-PTBE-01, targeting larger patient group for PTBE treatment. Strengthened team with Dr. Kirsty Crame and Dr. Timm Trenktrog. Market opportunity in PTBE surpassing USD 1 billion

Curatis Holding AG Corticorelin PTBE Treatment Dr. Kirsty Crame Dr. Timm Trenktrog
BRIEF

published on 03/27/2025 at 07:05, 10 months 24 days ago

Curatis Reports 30% Revenue Growth and Expands Patient Target for Lead Project

Revenue Growth Cash Position FDA Meeting Biologics License Pediatric And Adult Tumors
BRIEF

published on 03/27/2025 at 07:05, 10 months 24 days ago

Curatis annonce une croissance de son chiffre d'affaires de 30 % et élargit sa cible de patients pour son projet phare

Croissance Des Revenus Situation De Trésorerie Réunion De La FDA Licence De Produits Biologiques Tumeurs Pédiatriques Et Adultes
PRESS RELEASE

published on 03/27/2025 at 07:00, 10 months 24 days ago

Curatis: Umsatzwachstum von 30% im Vertrieb - dazu deutliche Ausweitung Patientenzielgruppe beim Lead-Projekt C-PTBE-01
Curatis Holding AG reports 30% sales growth in distribution for 2024 and significant expansion in the targeted patient group for lead project C-PTBE-01

Sales Growth Distribution Curatis Holding AG C-PTBE-01 Patient Group
BRIEF

published on 03/11/2025 at 07:05, 11 months 9 days ago

Curatis crée un comité consultatif d'experts pour guider les innovations dans le domaine de la santé

Conseil Consultatif Curatis Holding SA Sciences Médicales Innovation Dans Le Domaine De La Santé Initiatives De Recherche
BRIEF

published on 03/11/2025 at 07:05, 11 months 9 days ago

Curatis Establishes Expert Advisory Board to Guide Healthcare Innovations

Advisory Board Healthcare Innovation Curatis Holding AG Medical Science Research Initiatives
PRESS RELEASE

published on 03/11/2025 at 07:00, 11 months 9 days ago

Curatis Announces Formation of Distinguished Advisory Board
Curatis Holding forms Advisory Board of renowned medical and scientific experts to drive research and innovation in healthcare. Details about the board members and company's mission provided

Advisory Board Research Healthcare Innovation Curatis Holding Medical Science
BRIEF

published on 11/14/2024 at 07:05, 1 year 3 months ago

Curatis va demander une licence biologique pour le C-PTBE-01 aux États-Unis

Curatis Holding SA C-PTBE-01 Demande De Licence Biologique Protection Du Marché Gliome Diffus De La Ligne Médiane
BRIEF

published on 11/14/2024 at 07:05, 1 year 3 months ago

Curatis to Apply for Biologic License for C-PTBE-01 in the USA

Diffuse Midline Glioma Curatis Holding AG C-PTBE-01 Biologic License Application Market Protection
PRESS RELEASE

published on 11/14/2024 at 07:00, 1 year 3 months ago

Curatis wird für C-PTBE-01 in den USA eine Biologic License beantragen - damit erhöht sich die Dauer des Marktschutzes in den USA markant im Falle einer Zulassung
Curatis Holding AG plans to apply for a Biologic License (BLA) for C-PTBE-01 in the USA, extending market protection significantly if approved

USA Curatis Holding AG C-PTBE-01 Biologic License Application Market Protection

Published on 02/20/2026 at 18:30, 1 hour 45 minutes ago

Sparta Updates Delay in Filing Annual Financial Statements
Published on 02/20/2026 at 15:45, 4 hours 30 minutes ago

Revolve Announces Closing of Initial US$10 Million Advance on Strategic Financing With Callaway
Published on 02/20/2026 at 14:30, 5 hours 45 minutes ago

Norse Gold Announces Application for Reactivation to TSX-V, Private Placement Financing and Stock Options Grant
Published on 02/20/2026 at 14:08, 6 hours 7 minutes ago

Datavault AI Announces Anticipated Launch of Josh Gibson Stablecoin and Josh Gibson NIL Strategies for Its Forthcoming NIL Exchange
Published on 02/20/2026 at 14:00, 6 hours 15 minutes ago

Nextech3D.ai's Eventdex Platform Powers AI Matchmaking for the SBA's CT Business Matchmaker Event Featuring Government Agencies and Major Prime Contractors

View all ACCESSWIRE

Published on 02/20/2026 at 18:36, 1 hour 39 minutes ago

EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 1 hour 44 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:23, 1 hour 52 minutes ago

POS-Transaction in Own Shares
Published on 02/20/2026 at 18:00, 2 hours 15 minutes ago

Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme
Published on 02/20/2026 at 18:00, 2 hours 15 minutes ago

Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations

View all EQS

Published on 02/20/2026 at 19:29, 46 minutes ago

SFPI GROUP: Liquidity agreement report S2 2025
Published on 02/20/2026 at 19:29, 46 minutes ago

SFPI GROUP: bilan du contrat de liquidité S2 S025
Published on 02/20/2026 at 18:00, 2 hours 15 minutes ago

TERACT - Termination of liquidity agreement
Published on 02/20/2026 at 18:00, 2 hours 15 minutes ago

TERACT - Résiliation du contrat de liquidité
Published on 02/20/2026 at 17:35, 2 hours 40 minutes ago

CHIFFRE D'AFFAIRES 2025

View all LES ECHOS COMFI WIRE

News